Dérivés des Purines et Pyrimidines
Les purines possèdent une structure bicyclique, composée d’un cycle à six membres fusionné avec un cycle à cinq membres, tous deux contenant des atomes d’azote à des positions clés. Les dérivés des purines, tels que l’adénine et la guanine, sont essentiels à la formation de l’ADN et de l’ARN. Ces composés ont des applications thérapeutiques dans le traitement du cancer et des maladies virales en inhibant la réplication cellulaire. Les pyrimidines, quant à elles, possèdent une structure monocyclique à six membres avec deux atomes d’azote. Leurs dérivés, tels que la cytosine, la thymine et l’uracile, sont également des composants essentiels de l’ADN et de l’ARN et sont utilisés en chimiothérapie et dans les traitements antiviraux.
Chez CymitQuimica, nous proposons des dérivés des purines et pyrimidines pour la recherche en biologie moléculaire, génomique et le développement de thérapies innovantes.
8881 produits trouvés pour "Dérivés des Purines et Pyrimidines"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
(S)-Methyl-L-thiocitrulline.Dihydrochloride
CAS :<p>M02076 - (S)-Methyl-L-thiocitrulline.Dihydrochloride</p>Formule :C7H17Cl2N3O2SDegré de pureté :>98%Masse moléculaire :278.192,6-Dimorpholin-4-ylpyrimidine-4-carboxylic acid
CAS :Degré de pureté :95.0%Masse moléculaire :294.31100463867194,6-Dimethoxy-2-[phenyl(piperazin-1-yl)methyl]pyrimidine
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :314.38900756835944-Chloro-2-pyridin-2-yl-6-pyridin-3-ylpyrimidine
CAS :Degré de pureté :95.0%Masse moléculaire :268.700012207031254-(4-Pyrimidin-4-yl-1H-pyrazol-1-yl)benzoic acid
CAS :Degré de pureté :95.0%Couleur et forme :SolidMasse moléculaire :266.260009765625Theophylline
CAS :<p>Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or included</p>Formule :C7H8N4O2Couleur et forme :White PowderMasse moléculaire :180.17 g/molPemetrexed Tromethamide (N2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-N5-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-L-glutamine)
<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formule :C24H30N6O8Couleur et forme :Off-White SolidMasse moléculaire :530.21251Caffeine
CAS :<p>Caffeine and its salts</p>Formule :C8H10N4O2Couleur et forme :White Crystalline Powder NeedlesMasse moléculaire :194.08038Clopidogrel R-Enantiomer ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C15H15ClN2OSCouleur et forme :White Off-White SolidMasse moléculaire :306.05936Febuxostat Related Compound D (2-[4-(sec-Butoxy)-3-cyanophenyl]-4-methylthiazole-5-carboxylic acid)
CAS :<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formule :C16H16N2O3SCouleur et forme :Off-White Fine PowderMasse moléculaire :316.08816Pemetrexed Disodium (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate)
CAS :<p>Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure</p>Formule :C20H19N5Na2O6·7H2OCouleur et forme :White PowderMasse moléculaire :597.18702Aspirin
CAS :<p>Ortho-acetylsalicylic acid (aspirin), its salts and esters</p>Formule :C9H8O4Couleur et forme :White Colorless SolidMasse moléculaire :180.04226Imidazole (1H-Imidazole)
CAS :<p>Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi</p>Formule :C3H4N2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :68.03745Methylbenzhydrol (2-Methylbenzhydrol)
CAS :<p>Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoi</p>Formule :C14H14OCouleur et forme :White PowderMasse moléculaire :198.10447Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C15H14ClNO2S·HClCouleur et forme :Off-White PowderMasse moléculaire :307.04338Allopurinol
CAS :<p>Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure</p>Formule :C5H4N4OCouleur et forme :White PowderMasse moléculaire :136.03851Acetaminophen
CAS :<p>Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof</p>Formule :C8H9NO2Couleur et forme :White PowderMasse moléculaire :151.06333Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS :<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formule :C15H14N2O3SCouleur et forme :White Fine PowderMasse moléculaire :302.07251Clopidogrel-β-D-glucuronide ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C21H22ClNO8SCouleur et forme :White Off-White SolidMasse moléculaire :483.07547Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C16H13ClNO2S·ClCouleur et forme :Off-White SolidMasse moléculaire :318.03555Clopidogrel Bisulfate
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C16H16ClNO2S·H2SO4Couleur et forme :White Off-White PowderMasse moléculaire :321.05903Pemetrexed Dimethyl Ester (dimethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate)
CAS :<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formule :C22H25N5O6Couleur et forme :Off-White SolidMasse moléculaire :455.18048Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C16H17Cl2NO2SCouleur et forme :White Off-White PowderMasse moléculaire :357.03571Triacetin
CAS :<p>Esters of acetic acid not elsewhere specified or included</p>Formule :C9H14O6Couleur et forme :Colorless Oily LiquidMasse moléculaire :218.21Pemetrexed Sodium 5-Methyl Ester ((S)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-5-methoxy-5-oxopentanoic acid, sodium salt)
CAS :<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formule :C21H22N5O6·NaCouleur et forme :Pale Yellow SolidMasse moléculaire :440.15701Caffeine Related Compound D (3,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS :<p>Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoi</p>Formule :C7H8N4O2Couleur et forme :White Crystalline PowderMasse moléculaire :180.06473Pemetrexed Disodium Enantiomer ((2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium salt)
CAS :<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formule :C20H19N5O6NaCouleur et forme :Pale Green SolidMasse moléculaire :576.5Pemetrexed Acid N-Hydroxysuccinimide Ester (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate)
CAS :<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formule :C19H17N5O5Couleur et forme :White Off-White SolidMasse moléculaire :395.12297Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS :<p>Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Formule :C16H20N2O·HClCouleur et forme :White SolidMasse moléculaire :256.15756Ondansetron Related Compound D (1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one)
CAS :<p>Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoi</p>Formule :C14H13NOCouleur et forme :White Off-White PowderMasse moléculaire :211.09971Caffeine Related Compound C (1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione)
CAS :<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formule :C8H10N4O2Couleur et forme :White Fine PowderMasse moléculaire :194.08038Tetrahydrothienopyridine Hydrochloride (4,5,6,7-Tetrahydrothieno[3,2-c]pyridine, hydrochloride)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C7H9NS·HClCouleur et forme :Off-White SolidMasse moléculaire :139.04557Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS :<p>Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formule :C7H9N3O3Couleur et forme :White Off-White PowderMasse moléculaire :183.06439Clopidogrel Acid N-Oxide (5-((S)-carboxy(2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C15H14ClNO3SCouleur et forme :White Off-White SolidMasse moléculaire :323.03829Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C16H16ClNO3SCouleur et forme :Pale Yellow SolidMasse moléculaire :337.05394Methyl 2-chloro-β-D-phenylalanine (methyl (R)-2-amino-2-(2-chlorophenyl)acetate, hydrochloride)
CAS :<p>Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoi</p>Formule :C9H10ClNO2·HClCouleur et forme :White Off-White SolidMasse moléculaire :235.01668Clopidogrel Diester Analog (R)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C24H21Cl2NO4S·H2SO4Couleur et forme :White Off-White SolidMasse moléculaire :587.02421Clopidogrel Ethyl Ester Sulfate (ethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate)
CAS :<p>Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi</p>Formule :C17H18ClNO2S·H2O4SCouleur et forme :White Off-White SolidMasse moléculaire :335.07468Ondansetron Hydrochloride
CAS :<p>Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoi</p>Formule :C18H19N3O·HCl·2H2OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Caffeine Related Compound F (1,7-Dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS :<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formule :C7H8N4O2Couleur et forme :White Fine PowderMasse moléculaire :180.06473Ondansetron Resolution Mixture
<p>Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoi</p>Couleur et forme :Off-White White PowderPemetrexed Glutamide Sodium ((S)-4-((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanamido)-4-carboxybutanoate, sodium salt)
CAS :<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formule :C25H27N6O9·NaCouleur et forme :Blue SolidMasse moléculaire :555.18395Febuxostat Related Compound C (Ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate)
CAS :<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formule :C14H12N2O3SCouleur et forme :Off-White Fine PowderMasse moléculaire :288.05686Pemetrexed Glutamide Trisodium Salt (((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)-4-carboxybutanoyl)-L-glutamic acid, sodium salt)
CAS :<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formule :C25H28N6O9·3NaCouleur et forme :Off-White SolidMasse moléculaire :556.19178Orphenadrine Citrate
CAS :<p>Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoi</p>Formule :C18H23NO·C6H8O7Couleur et forme :White Crystalline PowderMasse moléculaire :269.17796Febuxostat
CAS :<p>Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure</p>Formule :C16H16N2O3SCouleur et forme :White Off-White PowderMasse moléculaire :316.08816
![4,6-Dimethoxy-2-[phenyl(piperazin-1-yl)methyl]pyrimidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF023778.webp&w=3840&q=75)
![Pemetrexed Disodium (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)e…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1500659.webp&w=3840&q=75)
![Clopidogrel Related Compound B (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1140597.webp&w=3840&q=75)
![Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478593.webp&w=3840&q=75)
